Mount Sinai Heart

Mount Sinai Heart is among the world's leading centers for cardiovascular medicine and advanced diagnostic and therapeutic technologies, successfully treating cardiac conditions from chronic arrhythmias to sudden heart attacks. 

This specialty report highlights:

  • A clinical trial of a new chemical treatment that extends the life of biological heart valves made from bovine pericardial tissue that is implanted in humans
  • A groundbreaking trial testing the efficacy of a new ventricular assist device (VAD) intended to provide hemodynamic support in patients with advanced refractory left ventricular heart failure
  • Research into the technological advancement of echocardiology through robotics, machine intelligence and mobile devices
  • A first-in-class small-molecule drug that may open a molecular pathway in the treatment of heart failure